Eikonizo Therapeutics
Stuart L. Schreiber is on the Board of Advisors at Eikonizo Therapeutics. Stuart is also a Professor at Harvard University.
This person is not in the org chart
This person is not in any offices
Eikonizo Therapeutics
Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.